Browsing Tag
Axonics
4 posts
Is neuromodulation entering its next growth cycle? Lessons from Medtronic, Axonics, and Boston Scientific
Neuromodulation is moving into its next growth cycle. Explore how Medtronic, Boston Scientific, and Axonics are reshaping bladder control and chronic care.
From stigma to scale: How bladder control therapies are evolving from hidden struggle to healthcare priority
Bladder control therapies are moving from stigma to mainstream care. Discover how rising awareness and innovation are reshaping treatment options globally.
Medtronic stock dips even as FDA clears Altaviva device for bladder control breakthrough
Medtronic (NYSE: MDT) wins FDA approval for Altaviva, a minimally invasive bladder control device. Find out why the stock fell and what it means for investors.
Boston Scientific to enhance urology portfolio by acquiring Axonics in $3.7bn deal
Boston Scientific Corporation (NYSE: BSX) has entered into a definitive agreement to acquire Axonics, Inc. (Nasdaq: AXNX), a…